Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Changweishu is an oral traditional Chinese medicine product marketed as **肠胃舒胶囊**. Public sources support at least one capsule formulation indicated in Chinese medicine for spleen and stomach damp-heat patterns, with reported actions such as clearing heat and drying dampness, regulating qi, relieving pain, and helping control diarrhea or dysenteric symptoms. The best-supported formulation identified from public drug-information sources is a multi-herb capsule containing **tsaoko cardamom fruit, costus root, valerian-like spider herb, purple sanguisorba, and dragon's blood resin**; it has been associated with Yunnan Youke and studied clinically in China for damp-heat syndrome of the spleen and stomach. Because traditional Chinese patent medicines sold under the same transliterated English name can appear in discrepant online formularies, the exact ingredient set should be verified at the product-manufacturer level before downstream structured use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Changweishu.